H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Neutral rating and $1.50 price target on Aethlon Medical (NASDAQ: AEMD).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE